ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,471,161	1,275,235	1,647,649	2,596,915	1,936,493	555,949
Market Cap Growth	40.60%	-22.60%	-36.55%	34.10%	248.32%	50.51%
Enterprise Value	1,468,238	1,375,695	1,714,024	2,628,966	1,910,417	481,544
Last Close Price	73000.00	67410.34	86388.45	136510.46	101442.21	29123.10
PE Ratio	41.01	65.13	91.54	784.06	-	-
Forward PE	31.69	37.69	67.19	133.19	-	-
PS Ratio	5.20	4.47	6.61	15.68	15.60	5.96
PB Ratio	2.92	3.30	4.83	7.97	6.53	1.83
P/TBV Ratio	4.28	3.44	5.07	8.37	6.79	1.91
P/FCF Ratio	55.21	-	-	-	-	-
P/OCF Ratio	38.03	982.17	234.34	357.22	-	-
EV/Sales Ratio	5.36	4.83	6.88	15.87	15.39	5.16
EV/EBITDA Ratio	27.69	24.33	48.35	131.50	-	-
EV/EBIT Ratio	53.49	41.05	96.02	471.35	-	-
EV/FCF Ratio	55.10	-	-	-	-	-
Debt / Equity Ratio	0.25	0.50	0.39	0.33	0.43	0.05
Debt / EBITDA Ratio	2.36	3.40	3.79	5.38	-	-
Asset Turnover	0.42	0.46	0.47	0.35	0.32	0.27
Inventory Turnover	1.20	1.54	1.72	1.75	2.45	2.33
Quick Ratio	1.87	2.53	0.82	3.00	10.07	6.21
Current Ratio	4.00	4.16	1.47	4.64	12.66	8.88
Return on Equity (ROE)	6.94%	4.81%	5.25%	1.08%	-4.38%	-5.84%
Return on Assets (ROA)	2.47%	3.36%	2.09%	0.74%	-2.99%	-4.87%
Return on Capital (ROIC)	2.78%	3.97%	2.45%	0.81%	-3.17%	-5.13%
Return on Capital Employed (ROCE)	4.30%	5.70%	4.60%	1.30%	-	-
Earnings Yield	2.36%	1.54%	1.09%	0.13%	-0.63%	-3.33%
FCF Yield	1.81%	-3.29%	-3.24%	-1.71%	-1.96%	-6.61%
Dividend Yield	0.67%	0.74%	-	-	-	-
Payout Ratio	27.09%	48.03%	52.25%	-	-	-
Buyback Yield / Dilution	-1.91%	-	-0.77%	-0.05%	-	-
Total Shareholder Return	-1.24%	0.74%	-0.77%	-0.05%	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.